Two of the biggest players in the dental products space are merging to become a multi-billion powerhouse.
Dentsply International (York, Pa.) and Sirona Dental Systems (Long Island City, N.Y.) will merge in an all-stock transaction totaling $13.3 billion. This is a true "merger of equals" and not a typical acquisition,a source close to the matter told Medical Device Daily.
Obtaining FDA approval for a product doesn't mean a company can rest on its laurels. In many cases, the work is really just beginning said Veracyte's (South San Francisco) President/CEO Bonnie Anderson. After approval comes the process of compiling a compelling body of post market data to help drive adoption rates. Nearly four years after obtaining FDA approval for the Afirma gene expression classifer (GEC), a test that is able to identify patients, whose thyroid nodules are noncancerous, Veracyte is in the process of garnering data.
In a bid to boost its infection prevention and control offerings in the gastrointestinal endoscopy market, Cantel Medical (Little Falls, N.J.) said it was acquiring Medical Innovations Group (Essex, UK) for nearly $80 million. Established in 1997, (as Medicart International), the company eventually grew to become the Medical Innovations Group, and specializes in endoscope storage and transport systems.
About 17 years ago, James Muller's vision of developing an intravascular imaging device to advance the diagnosis and management of coronary artery disease hit a turning point. Muller, a former professor of medicine at Harvard Medical School (Boston) founded Infraredx(Burlington, Mass.) to get the imaging device to market.
Shares of Tandem Diabetes (NASDAQ:TNDM) (San Diego) were up as high as 12.5% yesterday as the company revealed it had received FDA approval for its t:slim G4 insulin pump. The device is a touch-screen pump with continuous glucose monitoring (CGM) integration, for use by people 12 years of age or older who use insulin.
